Xlera8

Nasal spray to prevent COVID infection begins clinical trials

The spray was developed to both prevent the virus infecting nasal cells in the first place and to reduce viral transmission in those already with COVID-19

An innovative clinical trial is set to commence in Australia testing whether a common blood thinning drug can prevent SARS-CoV-2 infection. The drug is administered by nasal spray and researchers believe it can block the virus from initially infecting cells in the nose.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: Coronavirus (COVID-19), New Atlas Audio

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://newatlas.com/health-wellbeing/nasal-spray-heparin-coronavirus-infection-clinical-trial/

Chat with us

Hi there! How can I help you?